Experimental Ebola Drug Shows More Promise

Ebola, the deadly virus, that had killed more than 10,000 people in Western Africa, has no vaccine against it. The US Food and Drug Administration is yet to approve any therapeutic drugs or vaccines against the virus. Now scientists in America have found out a promising Ebola drug against the virus. They have found out that the potential drug is capable of treating 90% of the mice exposed to the virus.

Researchers all around the World are working to develop the vaccine against the virus. Some are investigating number of compounds or molecules. They found that those 70 to 90% of the mice infected with ebola survived after getting treatment with the non-toxic compounds they have formulated. The survived mice did not showed up any side effects.

Tidbits
  • The FDA was formed in 1906 and it has its headquarters in unincorporated White Oak, Maryland.
  • The FDA is responsible for protecting and promoting public health.
  • Fruit bats are believed to be the normal carrier of the Ebola virus.
  • Ebola has a high risk of death, killing between 25 and 90 percent of those infected, with an average of about 50 percent